Pathology of Hematologic Malignancies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 208
Special Issue Editor
2. Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Interests: leukemia; lymphoma; myeloid neoplasm; molecular diagnostics and genetics
Special Issue Information
Dear Colleagues,
Hematologic malignancies occur at all ages and can present as diseases of blood, lymph nodes, or solid organs. They can be indolent low-grade neoplasms or very aggressive, leading to death in a very short time. The classification of hematologic malignancies is based on clinical features, histology factors, immunophenotypes, as well as cytogenetic and molecular findings. Notably, in recent years, there is more knowledge on genetic changes in hematologic malignancies that has further impacted diagnostic criteria, as well as the development of the targeted treatment of these patients. As a result of the significant progress in the characterization of hematologic malignancies, particularly new insights provided by genomic studies, there are two recent classification proposals: International Consensus Classification (ICC) and the 5th edition of the World Health Organization (WHO)’s classification of hematolymphoid tumors.
This Special Issue of Cancers, titled “Pathology of Hematologic Malignancy”, aims to showcase original research articles or comprehensive review articles focused on significant clinicopathological, immunophenotypic, and genetic findings that can contribute to refining diagnostic, prognostic, or treatment criteria.
Dr. Aida I. Richardson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematologic malignancy
- acute leukemia
- lymphoma
- lymphoproliferative disorder
- myeloid neoplasm
- genetic abnormalities
- pediatric and/or germline mutation-associated disorders
